Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Net Income (2021 - 2025)

Historic Net Income for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to -$46.0 million.

  • Rxo's Net Income fell 8400.0% to -$46.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$100.0 million, marking a year-over-year increase of 6551.72%. This contributed to the annual value of -$100.0 million for FY2025, which is 6551.72% up from last year.
  • Rxo's Net Income amounted to -$46.0 million in Q4 2025, which was down 8400.0% from -$14.0 million recorded in Q3 2025.
  • Over the past 5 years, Rxo's Net Income peaked at $44.0 million during Q2 2022, and registered a low of -$243.0 million during Q3 2024.
  • For the 5-year period, Rxo's Net Income averaged around -$12.9 million, with its median value being -$4.0 million (2022).
  • As far as peak fluctuations go, Rxo's Net Income soared by 15000.0% in 2023, and later crashed by 2420000.0% in 2024.
  • Quarter analysis of 5 years shows Rxo's Net Income stood at $42.0 million in 2021, then crashed by 109.52% to -$4.0 million in 2022, then skyrocketed by 150.0% to $2.0 million in 2023, then tumbled by 1350.0% to -$25.0 million in 2024, then crashed by 84.0% to -$46.0 million in 2025.
  • Its last three reported values are -$46.0 million in Q4 2025, -$14.0 million for Q3 2025, and -$9.0 million during Q2 2025.